In neuroblastoma cells, P2X7 inhibition not only reduced tumor progression but was also shown to influence metabolic activity via Akt pathway and angiogenesis through reduced vascular endothelial growth factor (VEGF) secretion (Amoroso et al., 2015). This evidence concerns the gene P2RX7 and neuroblastoma.